Qiagen (QGEN) Competitors

Qiagen (NYSE:QGEN) and argenx (NASDAQ:ARGX) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, community ranking, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

Do analysts prefer QGEN or ARGX?

Qiagen presently has a consensus target price of $48.42, suggesting a potential upside of 14.61%. argenx has a consensus target price of $698.11, suggesting a potential upside of 19.35%. Given argenx's stronger consensus rating and higher probable upside, analysts clearly believe argenx is more favorable than Qiagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Qiagen	0 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.30
argenx	0 Sell rating(s)	1 Hold rating(s)	20 Buy rating(s)	2 Strong Buy rating(s)	3.04

Does the media refer more to QGEN or ARGX?

In the previous week, argenx had 6 more articles in the media than Qiagen. MarketBeat recorded 22 mentions for argenx and 16 mentions for Qiagen. argenx's average media sentiment score of 1.19 beat Qiagen's score of 1.15 indicating that argenx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Qiagen	11 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
argenx	16 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer QGEN or ARGX?

argenx received 412 more outperform votes than Qiagen when rated by MarketBeat users. Likewise, 67.52% of users gave argenx an outperform vote while only 60.19% of users gave Qiagen an outperform vote.

Company	Underperform	Outperform
Qiagen	Outperform Votes 251 60.19%	Underperform Votes 166 39.81%
argenx	Outperform Votes 663 67.52%	Underperform Votes 319 32.48%

Is QGEN or ARGX more profitable?

Qiagen has a net margin of 4.23% compared to argenx's net margin of -2.11%. Qiagen's return on equity of 13.92% beat argenx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Qiagen	4.23%	13.92%	8.40%
argenx	-2.11%	-1.45%	-1.29%

Which has more risk and volatility, QGEN or ARGX?

Qiagen has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, argenx has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500.

Which has higher earnings and valuation, QGEN or ARGX?

Qiagen has higher earnings, but lower revenue than argenx. argenx is trading at a lower price-to-earnings ratio than Qiagen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Qiagen	$2.00B	4.69	$83.59M	$0.40	105.61
argenx	$2.58B	13.84	-$295.05M	$16.21	36.09

Do institutionals & insiders have more ownership in QGEN or ARGX?

70.0% of Qiagen shares are owned by institutional investors. Comparatively, 60.3% of argenx shares are owned by institutional investors. 9.0% of Qiagen shares are owned by company insiders. Comparatively, 2.4% of argenx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

argenx beats Qiagen on 11 of the 19 factors compared between the two stocks.